Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Dermatology Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Dermatology Other
    Converting to Sirolimus From Calcineurin Inhibitors Reduces Risk of Skin Cancer in Kidney Transplant Patients: Presented at Renal Week 2009 - (DGDispatch)
    Spinosad Better Than Permethrin for Pediculosis Capitis in Children: Presented at AAP - (DGDispatch)
    Topical Onychomycosis Treatment More Effective Than Oral Treatment : Presented at EADV - (DGDispatch)
    Mycophenolate Mofetil Benefits Patients With Pemphigus Vulgaris: Presented at EADV - (DGDispatch)
    Health Canada Approves Telavancin for Complicated Skin, Skin Structure Infections - (DGNews)

    News archive

     Recent webcasts/CME - Dermatology Other
      The Prevention and Treatment of Pressure Ulcers
      Contemporary Options for the Management of Scars
      Pediatric and Adolescent Sports-Related Injuries and Ailments
      The Wound Healing Process
      Current Concepts in Healing Chronic Diabetic Foot Ulcerations

      Webcasts/CME archive

       Recent cases - Dermatology Other
        Yellow Nail Syndrome
        Acquired Perforating Dermatosis: Association with Diabetes and Renal Failure
        Complete Remission of Severe Idiopathic Cold Urticaria on Interleukin-1 Receptor Antagonist (Anakinra)
        Ulcerative Leg Nodules in a Transplant Recipient
        Pearly Penile Papules

        Cases archive
          




        my personal edition > dermatology other > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Tretinoin Emollient Cream Safe And Effective for Long-Term Treatment of Wrinkles and Hyperpigmentation: Presented at AAD

        By Alison Palkhivala

        SAN FRANCISCO, CA -- March 26, 2003 -- Long-term use of 0.05% tretinoin emollient cream safely improves the problems associated with photodamaged skin, such as wrinkling and mottled hyperpigmentation, according to a multicentre study.

        Lead researcher Sewong Kang, MD, from the department of dermatology, University of Michigan, Ann Arbor, United States, presented the findings here on March 22nd at the 61st Annual Meeting of the American Academy of Dermatology.

        The study included 204 patients aged 30 to 75 with lightly pigmented and/or moderate to severe photodamaged skin, who were randomised to treatment with a 0.05% tretinoin emollient cream or a vehicle alone (placebo).

        Among the 160 patients who completed the 24-month treatment period, those using the tretinoin cream had significantly better improvements than those who used the placebo with respect to fine wrinkling and mottled hyperpigmentation (p=0.002 for both). There was no difference between the two groups with respect to tactile roughness.

        In terms of secondary end points, the tretinoin cream was also significantly superior to placebo with respect to improving coarse wrinkling (p=0.029), sallowness (p=0.008) and lentigines (p=0.006). Physicians' global assessment was also superior for patients using the tretinoin cream rather than the placebo (p=0.002).

        The most common adverse event associated with use of the tretinoin cream was mild cutaneous irritation, which peaked at 2 months.

        Based on these findings, the authors concluded that a tretinoin 0.05% cream offers long-term safety and efficacy for the treatment of fine wrinkles, mottled hyperpigmentation, coarse wrinkles, sallowness and lentigines in patients with moderate to severe photodamaged skin.

        Ortho Neutrogena sponsored the study.


        [Study title: Safety and Efficacy of Long-Term Use of Tretinoin Emolient Cream 0.05% for the Treatment of Photodamaged Facial Skin: Review of a Clinical Trial. Abstract p100]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send